IMCR 10-Q: SEC filing

Immunocore Holdings plc

Filed with the SEC on · accession 0001671927-26-000035

IMCR filed a 10-Q (quarterly report) with the SEC on Nov 6, 2026. Immunocore Holdings plc filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results including therapy sales, operating expenses, and balance sheet data.

Summary of the filing

Immunocore Holdings plc filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results including therapy sales, operating expenses, and balance sheet data. The filing contains standard XBRL-tagged financial data with no single material corporate event disclosed.

Key details

FilerImmunocore Holdings plc
Distribution partnerMedison
Distribution partnerEr Kim

✦ Ask GOAX AI about this filing — what it means for IMCR, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for IMCR?

Click here

Frequently asked questions

What did IMCR file with the SEC on Nov 6, 2026?

IMCR filed a 10-Q (SEC filing). Immunocore Holdings plc filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results including therapy sales, operating expenses, and balance sheet data. The filing contains standard XBRL-tagged financial data with no single material corporate event disclosed.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

Other IMCR SEC filings

Get alerts when IMCR files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days